Johann Rastetter

Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)

S. Danhauser-Riedl, E. Hausmann, Hans-D. Schick et al. · Investigational New Drugs · 1993 · 152 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Anti-tumor action of alkyl-lysophospholipids (Review).

Berdel We, Bausert Wr, U. Fink et al. · PubMed · 1981 · 80 citations

Medicine, Oncology, Pharmacology +16

Clinical phase I pilot study of the alkyl lysophospholipid derivative ET‐18‐OCH₃

Wolfgang E. Berdel, U. Fink, Johann Rastetter · Lipids · 1987 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +10

Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.

Wolfgang E. Berdel, Michael Fromm, U. Fink et al. · PubMed · 1983 · 64 citations

Medicine, Oncology, Pharmacology +9

Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells

H. Depenbrock, S. Schmelcher, Robert Peter et al. · European Journal of Cancer · 1997 · 54 citations

Medicine, Oncology, Pharmacology +6